APTALIS PHARMA INC Comprehensive Income
APTALIS PHARMA INC reported Comprehensive Income of $13.75 million for the 3-month period ending 2011-12-31, per its 10-Q filed 2012-02-10.
Discontinued › Income Statement › Unrealized Gains
us-gaap:ComprehensiveIncomeNetOfTax · last filed 2012-02-10
- APTALIS PHARMA INC comprehensive income (loss), net of tax, attributable to parent for the quarter ending 2011-12-31 was $13.75M.
- APTALIS PHARMA INC comprehensive income (loss), net of tax, attributable to parent for the quarter ending 2011-09-30 was -$60.90M, a 1307.43% decline year-over-year.
- APTALIS PHARMA INC comprehensive income (loss), net of tax, attributable to parent for the quarter ending 2010-12-31 was -$583.00K.
- APTALIS PHARMA INC comprehensive income (loss), net of tax, attributable to parent for the quarter ending 2010-09-30 was $5.04M.
- APTALIS PHARMA INC comprehensive income (loss), net of tax, attributable to parent for fiscal 2011 was -$204.01M.
- APTALIS PHARMA INC comprehensive income (loss), net of tax, attributable to parent for fiscal 2010 was -$179.73M.
- APTALIS PHARMA INC comprehensive income (loss), net of tax, attributable to parent for fiscal 2009 was -$3.20M.
| Period end | Comprehensive Income (Loss), Net of Tax, Attributable to Parent 3 month | Comprehensive Income (Loss), Net of Tax, Attributable to Parent 6 month | Comprehensive Income (Loss), Net of Tax, Attributable to Parent 9 month | Comprehensive Income (Loss), Net of Tax, Attributable to Parent 12 month |
|---|---|---|---|---|
| 2011-12-31 | $13.75M 10-Q · filed 2012-02-10 | -$47.15M derived: sum of 2 quarters · filed 2012-02-10 | ||
| 2011-09-30 | -$60.90M derived: 10-K 12 month − 10-Q 9 month · filed 2011-12-20 | -$204.01M 10-K · filed 2011-12-20 | ||
| 2011-06-30 | -$143.11M 10-Q · filed 2011-08-12 | |||
| 2010-12-31 | -$583.00K 10-Q · filed 2012-02-10 | $4.46M derived: sum of 2 quarters · filed 2012-02-10 | ||
| 2010-09-30 | $5.04M derived: 10-K 12 month − 10-Q 9 month · filed 2011-12-20 | -$179.73M 10-K · filed 2011-12-20 | ||
| 2010-06-30 | -$184.77M 10-Q · filed 2011-08-12 | |||
| 2009-09-30 | -$3.20M 10-K · filed 2011-12-20 |